Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. SPCX
2. CRNX
3. USO
4. VRTX
5. RIVN
6. SPY
7. NVDA
8. LMT
9. WMT
10. CMPS

Go back to Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights

Matinas BioPharma (MTNB) Reports In-Line Q2 EPS

August 10, 2020 4:54 PM EDT

Matinas BioPharma (NYSE: MTNB) reported Q2 EPS of ($0.03), in-line with the analyst estimate of ($0.03).

We are pleased to announce that both the ENHANCE-IT study of MAT9001 and the... More